Deeper Trial - Asco 2021
Deeper Trial - Asco 2021
Deeper Trial - Asco 2021
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Backgrounds
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Objectives
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Methods
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Methods
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Methods
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Methods
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
CONSORT diagram
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
CONSORT diagram
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Patient characteristics
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Patient characteristics (cont.)
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Treatment disposition
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Depth of Response <primary endpoint>
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Waterfall Plot (Depth of Response)
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Waterfall Plot (Depth of Response)
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Depth of Response by tumor location
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Overall Response Rate
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Early Tumor Shrinkage (ETS) Rate <br />at week 8
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Toxicity
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Toxicity
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Toxicity
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Progression-Free Survival in the FAS population
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Overall Survival in the FAS population
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Conclusion
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Acknowledgments to
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
Institutions: JACCRO CC-13 Study Group <br />consists of 87 institutions
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.